• 검색 결과가 없습니다.

The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer

N/A
N/A
Protected

Academic year: 2021

Share "The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

AHBPSAnnals of Hepato-Biliary-Pancreatic Surgery

www.ahbps.org S155

The change of clinical stage after neoadjuvant

chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer

Byung-Chang KIM, Woohyung LEE*

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

BP-PP-2-1

Introduction: Response evaluation using computed tomography during neoadjuvant chemotherapy (NACT) is limited due to indis- tinct finding of fibrotic change around tumor. This study was aimed to investigate predictive role of change in clinical stage based on computed tomography (CT) during NACT n patients with borderline resectable pancreatic cancer (BRPC) and locally advanced pan- creatic cancer (LAPC).

Methods: BRPC and LAPC patients with NACT using FOLFIRINOX regimen were included between 2012 and 2019. The patients were divided into responsive, stationary, and aggravated groups based on the change of clinical stage in pre and post NACT CT imag- es. We compared short and long term outcomes among three groups.

Results: Responsive, stationary, aggravated group were found in 37 (22.1%), 116 (69.4%), and 16 (9.5%) patients, respectively. Of 45 patients in pre-NACT stage III, 9 (20%) patients showed downward stage migration in responsive group and 25 (41.5%) patients were showed upward stage migration in 60 patients with pre-NACT stage I. Responsive group showed the better 3-year recurrence free sur- vival rate compared with stationary and aggravated groups (44.2% vs. 23.5% vs. 0%; p = 0.001). Responsive group showed lower pro- portion of node metastasis (p = 0.048), lymphovascular invasion (p = 0.011) and smaller tumor size in pathology (p = 0.007) compared with other groups.

Conclusions: Responsive group was associated with better recurrence free survival in FOLFIRINOX based NACT. And it may be helpful to manage the patients postoperatively for finding the characteristics of responsive group during NACT for BRPC and LAPC.

pISSN: 2508-5778ㆍeISSN: 2508-5859

Ann Hepatobiliary Pancreat Surg 2021;25 Suppl 1:S155 https://doi.org/10.14701/ahbps.BP-PP-2-1

Corresponding Author: Woohyung LEE ([email protected]) Presenter: Byung-Chang KIM ([email protected])

Copyright Ⓒ The Korean Association of Hepato-Biliary-Pancreatic Surgery

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

참조

관련 문서

This study is based on the fact that demand for housing has been under the influence of change of population structure... people live in

Abstract: This study was aimed to investigate the adhesion control standards of pain relieving patch (PRP) drugs and to survey it′s adverse effects on the skin of patients

In this study, to investigate how applying a critical pathway to stomach cancer patients affects their recovery and treatment, the clinical effect of the critical

Objective: The purpose of this study was to investigate the effect of clinical practice satisfaction on professional self-concept among dental hygiene students.. Methods:

The purpose of this study was to investigate the change of body composition and physical fitness after 12 weeks of practice with middle-aged women centered

Results: Poorly differentiated colorectal cancer was frequently located at right colon and in advanced stage.. During follow-up, double primary cancer had occurred

Although visceral fat adiposity has known to be associated with clinical, pathologic, and oncologic outcomes in patients with colorectal cancer (CRC), the

In elderly metastatic colon cancer patients, the treatment results of combination therapy with targeted treatment showed similar results to those reported in clinical trials